Platelet Aggregation Devices Market Report by Product (Systems, Reagents, Consumables and Accessories), Type (Four Channel, Dual Channel, Eight Channel), Application (Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Ap

Platelet Aggregation Devices Market Report by Product (Systems, Reagents, Consumables and Accessories), Type (Four Channel, Dual Channel, Eight Channel), Application (Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2024-2032


The global platelet aggregation devices market size reached US$ 556.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 893.3 Million by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Platelet aggregation devices comprise adenosine-diphosphate (ADP), thrombin, and ristocetin-induced platelet aggregation (RIPA). These devices are used to diagnose patients with inherited and acquired platelet function disorders, such as excessive bleeding, arterial thrombotic, stroke, and myocardial infarction. They assist in transfusing medicines, pre-surgery tests, and clinical settings to monitor the response of antiplatelet therapies and assess perioperative bleeding risk. At present, due to the launch of new potential biomarkers and technologies, platelet aggregation devices are finding extensive application in personalizing antiplatelet drugs and monitoring the efficacy of various types of pro-hemostatic therapies around the world.

Platelet Aggregation Devices Market Trends:

The rising instances of platelet aggregation among patients diagnosed with coronavirus disease (COVID-19) are strengthening the growth of the market. Moreover, due to the growing prevalence of colon cancer, cardiovascular diseases, Kawasaki condition, acute coronary syndrome (ACS), acute ischemic stroke, and acute rheumatic disorders across the globe, there is an increase in the risk of bleeding. This acts as another key factor impelling the growth of the platelet aggregation devices market for clinical management of platelet function disorders. In addition, a significant rise in the aging population suffering from chronic diseases is contributing to the market growth. Apart from this, leading manufacturers are launching novel products to expand their product portfolio and retain a competitive edge in the market. They are also focusing on developing new and simpler point-of-care (POC) diagnostic devices. These devices rely on the latest methodologies for helping in the rapid evaluation of inherited and acquired bleeding disorders and antiplatelet therapies. This, coupled with the increasing need for POC diagnostic devices to fulfill the healthcare demand of the large population, is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global platelet aggregation devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, type, application and end user.

Breakup by Product:
  • Systems
  • Reagents
  • Consumables and Accessories
Breakup by Type:
  • Four Channel
  • Dual Channel
  • Eight Channel
Breakup by Application:
  • Clinical Applications
  • Research Applications
  • Cardiovascular Applications
  • Orthopedic Applications
  • Others
Breakup by End User:
  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aggredyne Inc., Chrono-Log Corporation, F. Hoffmann-La Roche AG, Grifols S.A., Hart Biologicals Ltd., Helena Laboratories Corporation, LAbor BioMedical Technologies GmbH, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco Inc., Sysmex Corporation and WerfenLife SA.

Key Questions Answered in This Report

1. What was the size of the global platelet aggregation devices market in 2023?

2. What is the expected growth rate of the global platelet aggregation devices market during 2024-2032?

3. What has been the impact of COVID-19 on the global platelet aggregation devices market?

4. What are the key factors driving the global platelet aggregation devices market?

5. What is the breakup of the global platelet aggregation devices market based on the product?

6. What is the breakup of the global platelet aggregation devices market based on the type?

7. What is the breakup of the global platelet aggregation devices market based on the application?

8. What is the breakup of the global platelet aggregation devices market based on the end user?

9. What are the key regions in the global platelet aggregation devices market?

10. Who are the key players/companies in the global platelet aggregation devices market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Platelet Aggregation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Systems
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Consumables and Accessories
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 Four Channel
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dual Channel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Eight Channel
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Clinical Applications
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Applications
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Applications
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Orthopedic Applications
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Research and Academic Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Aggredyne Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Chrono-Log Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F. Hoffmann-La Roche AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 Grifols S.A.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Hart Biologicals Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Helena Laboratories Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 LAbor BioMedical Technologies GmbH
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Matis Medical Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Sentinel Ch. S.P.A.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Siemens AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sienco Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Sysmex Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 WerfenLife SA
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings